e.g. mhealth
Search Results (1 to 10 of 17 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 12 JMIR Dermatology
- 2 JMIR Formative Research
- 1 JMIR Research Protocols
- 1 JMIR mHealth and uHealth
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
A recent systematic review and meta-analysis of mobile health applications for AD reported a significant improvement in patients’ quality of life (assessed by Dermatology Life Quality Index) and self-management (assessed by Patient-Oriented Eczema Measure [POEM]) but no significant impact on AD severity (assessed by SCORAD [Scoring Atopic Dermatitis]) [3].
JMIR Dermatol 2025;8:e60479
Download Citation: END BibTex RIS
Hand eczema is one of the most common dermatologic conditions responsible for a very large proportion of dermatological consultations. According to a systematic review and meta-analysis, the 1-year prevalence is estimated to be 9.1% in the general population [1].
The probability of developing hand eczema at least once in a lifetime is 17% [2]. This likelihood varies greatly depending on occupational groups.
J Med Internet Res 2025;27:e52159
Download Citation: END BibTex RIS
From the Cochrane Library: Leukotriene Receptor Antagonists for Eczema
A 2018 Cochrane review, “Leukotriene receptor antagonists for eczema” [6], examined clinical trials to determine if there is sufficient evidence to recommend LTRAs for use in patients with AD but concluded that there was limited, low-quality evidence of its efficacy and safety.
This Cochrane review extracted data across 5 studies and 202 participants to evaluate the evidence of LTRA effectiveness in AD.
JMIR Dermatol 2024;7:e50434
Download Citation: END BibTex RIS
The app uses a numerical rating scale for grading the severity of pruritus [9] and the patient-oriented eczema measure (POEM) [10] as a global severity score.
AI can assist in tailoring treatment plans for individuals with atopic eczema by analyzing patient data, including lifestyle factors, environmental conditions, and treatment responses. Attempts to develop accurate automated measurements of eczema severity using images have shown promising results.
JMIR Dermatol 2023;6:e49278
Download Citation: END BibTex RIS
Clinical Efficacy of Nutritional Supplements in Atopic Dermatitis: Systematic Review
Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin condition that presents with symptoms of intense pruritus, dryness, and erythema. In the acute phase, inflammatory changes are dominated by edema, vesicles, and weeping skin lesions, which lead to chronic cutaneous manifestations, including thickening of the skin and fibrosis [1]. AD has 2 classifications: intrinsic (endogenous) and extrinsic (exogenous).
JMIR Dermatol 2023;6:e40857
Download Citation: END BibTex RIS
Skin of Color Representation for Atopic Dermatitis on TikTok: Cross-Sectional Analysis
Tik Tok was searched with the term #eczema on July 27, 2022, and the first 136 videos were assessed. We included nonduplicative English videos with relevant content. Of the 136 videos, 119 met the inclusion criteria and 17 did not. Videos by board-certified physicians were categorized as physician; those by individuals without recognized medical qualifications were categorized as nonphysician.
JMIR Dermatol 2023;6:e48635
Download Citation: END BibTex RIS
The most common recent diagnosis was a general diagnosis of atopic dermatitis (n=3263, 50.8%), followed by vesicular eczema (n=1148, 17.9%), nummular eczema (n=1126, 17.5%), flexural eczema (n=763, 11.9%), and lastly, atopic neurodermatitis (n=12, 1.9%). Among those who received dupilumab, the mean age was 51.4 (SD 16.7) years and 58.6% (n=146) were female. Every patient who received a prescription had either multiple prescriptions, prescriptions for quantities greater than 1, or received refills.
JMIR Dermatol 2023;6:e41194
Download Citation: END BibTex RIS
Genetic predisposition, environmental factors, defects in skin barrier function, and immune dysregulation are known pathogenic factors; triggers, such as sweating, certain irritants, infections, and stress, can induce eczema and pruritus [2]. The resulting itch-scratch cycle can further damage the skin barrier and hypersensitize affected nerve fibers, some of which also function as pain receptors, and thus, itch is often accompanied by pain [5].
JMIR Form Res 2023;7:e41227
Download Citation: END BibTex RIS
Extradural symptoms, such as depression and anxiety disorders are common, and psychiatric comorbidity has been found to increase in correlation with more severe eczema [2]. One study on a UK sample found that 40% of people with AD had a depression- or anxiety-related diagnosis compared to 17% of people without AD [3]. Stress and negative emotions can lead to increased scratching and skin tearing behavior.
JMIR Dermatol 2023;6:e42360
Download Citation: END BibTex RIS
The user’s expectation from the home page was that she would learn more information about eczema research and upcoming clinical trials. She did not have any issues navigating the website and had no difficulty understanding its content. She believed the longer bars on the “Avoiding potentially dangerous side effects” domain meant more dangerous side effects. The wording was then changed to “Safety: Fewer Serious Adverse Events.”
JMIR Dermatol 2022;5(3):e41201
Download Citation: END BibTex RIS